Could Women's Use of 'the Pill' Raise Men's Prostate Cancer Risk?
New finding is highly speculative and doesn't demonstrate cause-and-effect, expert says
By Steven Reinberg
MONDAY, Nov. 14 (HealthDay News) -- With the vast increase in the use of the contraceptive pill over the past 40 years, the amount of estrogen entering the water supply may be partly responsible for the increased incidence of prostate cancer around the world, Canadian researchers speculate.
Excess estrogen is known to cause various cancers, and the widespread use of the pill might raise environmental levels of the hormone.
"Recent studies have shown that estrogen exposure may increase the risk of prostate cancer," said lead researcher Dr. David Margel, a clinical fellow in the Department of Surgical Oncology at Princess Margaret Hospital and the University of Toronto.
"We wanted to explore whether there was an association with a woman's use of oral contraceptives to prostate cancer incidence or mortality," he explained. Although the amounts of estrogen excreted by a woman is minimal, when millions of women do it over a long period of time, it might cause a low-level environmental contamination, Margel said.
The report is published online in the Nov. 14 edition of BMJ Open.
For the study, Margel and his colleague Dr. Neil E. Fleshner, researchers at the university's Health Network, used data from the International Agency for Research on Cancer and the United Nations World Contraceptive Use report to identify the rates of prostate cancer and prostate cancer deaths as well as the proportion of women using contraceptive pills.
Margel and Fleshner complied data on countries and continents around the world to see if there was any connection between contraceptive pills and prostate cancer.
The researchers looked at some 100 countries and found that where the use of oral contraceptives was high, so was the rate of prostate cancer. These findings did not change based on a nation's wealth, they added.
"It seems as if the European countries had the highest association," Margel said.
The use of other contraceptives such as intrauterine devices, condoms or other vaginal barriers was not associated with an increased risk of prostate cancer.
"I want to stress this is a hypothesis-generating study," Margel said. "In no way do we prove cause-and-effect."
To further explore the connection, the researchers are planning to test water and look for estrogen levels in patients with prostate cancer.
Prostate cancer is the most common male cancer in the developed world, and the use of the contraceptive pill is widespread, the researchers noted.
Prostate cancer expert Dr. Anthony D'Amico, chief of radiation oncology at Brigham and Women's Hospital in Boston, said that "it's hard to know if this is true. This is a study of association, not cause-and-effect. Even the hypothesis it's based on is questionable."
D'Amico noted that even if there is estrogen from contraceptives in drinking water or food, a person would have to drink the water and somebody would then have to measure the amount of estrogen in the blood. But even then, most compounds the body takes in are not absorbed, he added.
In fact, for a man to get micrograms of estrogen into the blood, he would have to ingest milligrams of estrogen. "You would have to have a lot in the water to believe this," D'Amico said.
D'Amico also said that small amounts of estrogen raise the risk for a heart attack. "If you have enough to cause prostate cancer, you also have enough to cause a heart attack -- so it's hard to accept."
Based on these speculative findings, "men should not be concerned," D'Amico said.
For more on prostate cancer, visit the U.S. National Cancer Institute.SOURCES: David Margel, M.D., clinical fellow, Department of Surgical Oncology, Princess Margaret Hospital, University of Toronto; Anthony D'Amico, M.D., Ph.D, chief, radiation oncology, Brigham and Women's Hospital, Boston; Nov. 14, 2011, BMJ Open Related Articles
- Bone Drugs May Protect Against Endometrial Cancer
December 22, 2014
- Lynparza Approved for Advanced Ovarian Cancer
December 19, 2014
Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.
Copyright © 2011 HealthDay. All rights reserved.